• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

DOBUTAMINE Drug Record

  • Summary
  • Interactions
  • Claims
  • DOBUTAMINE chembl:CHEMBL926 Approved

    Alternate Names:

    DOBUTREX
    DOBUTAMINE
    COMPOUND-81929
    COMPOUND 81929

    Drug Info:

    Drug Class cardiotonic agents
    Year of Approval 1978
    FDA Approval 1978
    Drug Class small molecule
    Drug Indications Cardiotonic Agents
    (2 More Sources)

    Publications:

    Rydén M et al., 2001, The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis., Int J Obes Relat Metab Disord
    Bruck et al., 2005, The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity., J. Am. Coll. Cardiol.
    La Rosée et al., 2004, The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines., Pharmacogenetics
    Junker et al., 2002, Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection., Eur. J. Pharmacol.
    Raddatz et al., 2006, Dobutamine improves liver function after hemorrhagic shock through induction of heme oxygenase-1., Am. J. Respir. Crit. Care Med.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Mao YM et al., 2009, Effect of 393T>C polymorphism of GNAS1 gene on dobutamine response in Chinese healthy subjects., J Clin Pharmacol
  • DOBUTAMINE   ADRB1

    Interaction Score: 2.48

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    11753577 16325050 15564877 12098582 16627864 11752352


    Sources:
    TdgClinicalTrial TEND PharmGKB TTD

  • DOBUTAMINE   GNAS

    Interaction Score: 1.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    19542315


    Sources:
    PharmGKB

  • DOBUTAMINE   DRD1

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: DOBUTAMINE

    • Version: 01-August-2011

    Alternate Names:
    DOBUTAMINE Primary Drug Name

    Drug Info:
    Year of Approval 1978
    Drug Class cardiotonic agents

    Publications:

  • TdgClinicalTrial: DOBUTAMINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Cardiotonic Agents
    Drug Class small molecule
    FDA Approval 1978

    Publications:

  • PharmGKB: dobutamine

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Mao YM et al., 2009, Effect of 393T>C polymorphism of GNAS1 gene on dobutamine response in Chinese healthy subjects., J Clin Pharmacol
    La Rosée et al., 2004, The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines., Pharmacogenetics
    Bruck et al., 2005, The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity., J. Am. Coll. Cardiol.

  • DTC: DOBUTAMINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL926 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: Dobutamine

    • Version: 2020.06.01

    Alternate Names:
    D0J7RK TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL926

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21